Associate Professor of Endocrinology, Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples

Research
The main clinical research concerns neuroendocrinology, specifically, the treatment of pituitary tumors and neuroendocrine tumors. The laboratory focuses on the cellular and molecular mechanisms underlying the effect of somatostatin, dopamine and their analogs in neoplastic cells of neuroendocrine origin.

Future projects
In the clinical field we will investigate the possibility of treating patients affected resistant tumors with new molecules that have different mechanisms of action. In addition, we will investigate the effects of somatostatin and dopamine receptors and their interaction on the therapeutic efficacy of selective compounds that bind to these receptor classes in neuroendocrine tumors.

Selected publications
Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 2003;349:2023-33.

Colao A, Spinelli L, Marzullo P, Pivonello R, Petretta M, Di Somma C, Vitale G, Bonaduce D, Lombardi G. High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. J Clin Endocrinol Metab 2003;88:3196-201.

Tauchmanovà L, Selleri C, De Rosa G, Pagano L, Orio F, Lombardi G, Rotoli B, Colao A. High prevalence of endocrine dysfunction in long-term survivors after bone marrow transplantation for haematological diseases. Cancer 2002;95:1076-84.

Colao A, Di Somma C, Salerno M, Spinelli L, Orio F Jr, Lombardi G. The cardiovascular risk of Growth Hormone-deficient adolescents. J Clin Endocrinol Metab 2002;87:3650-5.

Colao A, Spinelli L, Cuocolo A, Spiezia S, Bonaduce D, Salvatore M, Lombardi G. Cardiovascular consequences of early-onset growth hormone excess. J Clin Endocrinol Metab 2002;87:3097-104.